# Myfortic Versus Azathioprine in Systemic Lupus Erythematosus

> **NCT00504244** · PHASE3 · TERMINATED · sponsor: **Erasmus Medical Center** · enrollment: 12 (actual)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **DRUG:** switch to Myfortic
- **DRUG:** continuation of azathioprine

## Key facts

- **NCT ID:** NCT00504244
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-07
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2010-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00504244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00504244, "Myfortic Versus Azathioprine in Systemic Lupus Erythematosus". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00504244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*